These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients. Ruessmann HJ; J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerability of gabapentin in the treatment of patients with neuropathic pain. Results of an observational study involving 5620 patients]. Junker U; Brunnmüller U MMW Fortschr Med; 2003 Oct; 145(44):37. PubMed ID: 14655505 [No Abstract] [Full Text] [Related]
13. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851 [TBL] [Abstract][Full Text] [Related]
14. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. Dallocchio C; Buffa C; Mazzarello P; Chiroli S J Pain Symptom Manage; 2000 Oct; 20(4):280-5. PubMed ID: 11027910 [TBL] [Abstract][Full Text] [Related]
15. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Backonja MM Epilepsia; 1999; 40 Suppl 6():S57-9; discussion S73-4. PubMed ID: 10530684 [TBL] [Abstract][Full Text] [Related]
16. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. Lindner MD; Bourin C; Chen P; McElroy JF; Leet JE; Hogan JB; Stock DA; Machet F Exp Clin Psychopharmacol; 2006 Feb; 14(1):42-51. PubMed ID: 16503704 [TBL] [Abstract][Full Text] [Related]